Guggenheim S&P 500 Equal Weight Health Care ETF (RYH)
- Equity | Health/Biotechnology Funds
- Loading...
Best Fit Health/Biotechnology Funds ETFs
U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
| Best Fit Scorecard | |
|---|---|
| Costs | Good |
| Tracking Error | Excellent |
| Bid/Ask Ratio | Excellent |
| Holdings Diversity | Excellent |
Fund Description
The investment seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care Total Return. The fund will invest at least 90% of its net assets, plus any borrowings for investment purposes, in the equity securities included in the underlying index. The underlying index is an unmanaged equal weighted version of the S&P 500 Health Care Index that consists of the common stocks of the following industries: health care equipment and supplies, health care providers and services, and biotechnology and pharmaceuticals that comprise the Health Care sector of the S&P 500 Index. It is non-diversified.
Fund Snapshot Updated 05.21.2013
| Previous Close | $95.95 | Expense Ratio | 0.50% |
| YTD Return | 22.7% | Avg. 30-Day Volume | 9,240 |
| 1-Year Return | 35.3% | Market Cap | Loading... |
| Bid | $96.01 | Shares Outstanding | 1,350,000 |
| Ask | $96.07 | Dividends | $1.23 |
| Top 10 Holdings | |
|---|---|
| Actavis Inc (ACT) | 2.55% |
| Biogen Idec Inc (BIIB) | 2.31% |
| Regeneron Pharmaceuticals (REGN) | 2.28% |
| Abbvie Inc (ABBV) | 2.14% |
| Gilead Sciences Inc (GILD) | 2.14% |
| Wellpoint Inc (WLP) | 2.13% |
| Boston Scientific Corp (BSX) | 2.12% |
| Life Technologies Corp (LIFE) | 2.09% |
| Hospira Inc (HSP) | 2.05% |
| Aetna Inc New (AET) | 2.05% |
| % of Total Holdings | 21.80% |
